Stories

Oct. 08, 2025

How Testing Empowers Healthcare: Sysmex’s New Challenges in Hemostasis Testing Across EMEA

When we get injured, blood naturally clots. This is a sophisticated mechanism built into our bodies to protect life.

Blood not only has the power to stop bleeding but also to dissolve clots. When this balance is disrupted, it can lead to conditions such as strokes, heart attacks, or hemophilia. Hemostasis testing helps identify these risks and guides decisions on appropriate treatments and surgeries.

Sysmex is working to enhance the value of the hemostasis testing field and bring it to more medical institutions. As part of this effort, in the EMEA^* region, the company has shifted from indirect sales and service in certain countries and regions to a closer support structure with healthcare institutions. In just a year, Sysmex has established direct sales and customer care in over 20 countries, a major undertaking. Daria Dzharageti, head of hemostasis business operations for the EMEA region, explains the background behind this transformation.

*Europe, Middle East, and Africa

Delivering Reliable Solutions for Diverse Regional Challenges

Daria Dzharageti
Director, Hemostasis Business Line, Sysmex Europe SE

Daria: The EMEA region spans a wide range of healthcare environments and challenges. In Western Europe, an aging workforce and a shortage of experienced lab technicians are driving demand for advanced automation and digital solutions that can maintain both testing quality and efficiency. In contrast, in the Middle East and Africa, expanding access to testing is creating demand for easy-to-use instruments with robust basic performance, even for facilities adopting testing instruments for the first time. In Eastern Europe, government-led healthcare development has accelerated, with preoperative screening and other tests being widely implemented. Meeting these diverse needs requires listening to local voices and responding with flexibility.

Hemostasis testing, in particular, is highly sensitive to factors such as the type of diagnostic reagents and blood collection conditions, including temperature and sample volume. The process is delicate, and ensuring reliable results requires both specialized expertise and continuous support for healthcare professionals.

These complex and diverse challenges have prompted Sysmex to begin transitioning toward a customer support infrastructure that better reflects the needs and realities of frontline healthcare environments across the EMEA region.

Delivering Confidence Through a Dedicated Support Framework

To be truly trusted in the field of hemostasis testing, it takes not only advanced expertise but also the ability to respond appropriately to each clinical situation.

Daria: At Sysmex, we provide all new members joining the hemostasis team with an extensive training program that covers advanced topics such as the clinical value of testing and relevant medical guidelines. This reflects our commitment to cultivating a highly specialized team capable of delivering reliable support to healthcare professionals.

In addition, in each newly established local hemostasis support unit is staffed with specialized professionals, including field service engineers and application support specialists. These experts regularly visit medical facilities to directly provide the latest clinical information and other forms of support, ensuring tailored assistance across both technical and clinical domains.

We are also focusing on expanding digital education platforms and content to support the continuous professional development of healthcare professionals. This allows busy medical professionals to improve their skills anytime, anywhere.

Recently, one of Poland’s leading cancer treatment centers, which adopted Sysmex’s diagnostic solutions, held a training session for local healthcare professionals. In this session, they introduced how our technology and customer care are being utilized in daily cancer diagnosis and surgeries, and how they contribute to improving the quality of medical care. Every time we witness how the importance of hemostasis testing and the value of Sysmex’s products and services are being embraced across the region, we feel that our efforts to strengthen sales and customer care structures are beginning to bear fruit in the field.

Evolving Products and Services to Expand Diagnostic Horizons

In addition to strengthening our support structure, our products and services are constantly evolving.

Daria: Modern healthcare increasingly relies on combining multiple tests to gain a complete picture of a patient’s condition. Sysmex focuses on developing products and services with a holistic view of the diagnostic process, considering how they can contribute to improving the quality of care.

For example, our integrated testing solution “BloodScience Workcell,” which we have rolled out in the EMEA region, combines hematology and hemostasis testing into a single automated workflow. By streamlining previously separate processes, it improves efficiency—reducing manual tasks and speeding up results—which in turn supports better quality of healthcare services.

When implementing these solutions, we go beyond equipment installation to offer consulting services that support the overall operation of the laboratory. By reviewing testing processes and work pathways, we help to create environments where test results reach physicians more quickly, enabling earlier treatment decisions.

By improving the way testing is conducted, we help patients access the most appropriate treatment as quickly as possible. We believe this embodies Sysmex’s commitment to a “better healthcare journey,” built on expertise across a wide range of diagnostic fields.

An integrated diagnostic system combining hematology and hemostasis testing in a single automated line

A Long-Held Vision of Bringing the Power of Testing to More Patients

The expansion of direct sales and customer care for hemostasis testing now enables us to deliver comprehensive support directly to more healthcare facilities—from implementing testing systems to assisting with operations and providing education.

Daria: Our decade-long goal of gaining full market access in EMEA and delivering our technologies to more patients has finally been realized, and we are genuinely excited about the opportunity to expand the delivery of new value.

Reaching this milestone has brought both joy and a strong sense of achievement to the EMEA team. In a recent engagement survey, many team members reported that they feel proud to work at Sysmex.

Looking ahead, we will continue to tackle the unique healthcare challenges of each region and provide solutions that truly support the front lines. Through the evolution of hemostasis testing, we aim to build a future where more people can access high-quality healthcare, and alongside our colleagues, we will keep taking on these challenges.

Group photo of Sysmex EMEA's hemostasis team in front of the exhibition booth